Novo Integrated Sciences Inc. (NASDAQ: NVOS) Reports 129% YoY Revenue Growth In Q3 2021
Novo Integrated Sciences Inc. (NASDAQ: NVOS) has announced its Q3 2021 ended May 31, 2021, financial results in which the company reported revenue of $2.38 million, a 129.3% YoY increase. The easing of COVID-19 pandemic restriction helped drive revenue growth The revenue increase is attributed to the easing of COVID-19 related restrictions resulting in the company’s practitioners providing more in-person services to more patients compared to the period between March…